Enhancement of cytokine-mediated NF-κB activation by phosphatidylinositol 3-kinase inhibitors in monocytic cells

International Immunopharmacology

Volumn 6, Issue 6, 2006, Pages 908-915

  Choi, Eun Kyoung ^a   Jang, Ho Cheol ^a   Kim, Jae Hyung ^a   Kim, Hyun Jin ^a   Kang, Ho Cheol ^b   Paek, Yun Woong ^c   Lee, Hyun Chul ^b   Lee, Seung Hoon ^d   Oh, Won Mann ^a   Kang, In Chol ^a  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Gwangju Health College University   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

Interleukin 1; Nuclear factor B; Phosphatidylinositol 3 kinase; THP 1; Tumor necrosis factor

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 METHYLADENINE; CYCLOOXYGENASE 2; CYTOKINE; DNA; I KAPPA B; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; LY 303511; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BONE MARROW CELL; CELL LINE; CELL STRAIN HL 60; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; GENE EXPRESSION; HEP 2 CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STIMULUS RESPONSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CHROMONES; CYCLOOXYGENASE 2; CYTOKINES; ENDOTHELIAL CELLS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION; HL-60 CELLS; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MEMBRANE PROTEINS; MONOCYTES; MORPHOLINES; NF-KAPPA B; PHOSPHORYLATION; PIPERAZINES; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646087878     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.01.007     Document Type: Article

References (23)

1. Baeuerle P.A., and Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12 (1994) 141-179
2. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev 18 (2004) 2195-2224
3. Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci 30 (2005) 43-52
4. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
5. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2 (2002) 489-501
6. Choi E.K., Park H.J., Ma J.S., Lee H.C., Kang H.C., Kim B.G., et al. LY294002 inhibits monocyte chemoattractant protein-1 expression through a phosphatidylinositol 3-kinase-independent mechanism. FEBS Lett 559 (2004) 141-144
7. Reddy S.A., Huang J.H., and Liao W.S. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NF-κB and AP-1 activation. J Biol Chem 272 (1997) 29167-29173
8. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B., et al. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401 (1999) 82-85
9. Gustin J.A., Ozes O.N., Akca H., Pincheira R., Mayo L.D., Li Q., et al. Cell type-specific expression of the IκB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-κB activation. J Biol Chem 279 (2004) 1615-1620
10. Diaz-Guerra M.J., Castrillo A., Martin-Sanz P., and Bosca L. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J Immunol 162 (1999) 6184-6190
11. Guha M., and Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277 (2002) 32124-32132
12. Aksoy E., Vanden Berghe W., Detienne S., Amraoui Z., Fitzgerald K.A., Haegeman G., et al. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-κB activation and IFN-β synthesis downstream of Toll-like receptor 3 and 4. Eur J Immunol 35 (2005) 2200-2209
13. S6K is differentially inhibited by LY294002 and wortmannin. Endocrinology 142 (2001) 498-501
14. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269 (1994) 5241-5248
15. Blommaart E.F., Krause U., Schellens J.P., Vreeling-Sindelarova H., and Meijer A.J. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem 243 (1997) 240-246
16. Schmedtje Jr. J.F., Ji Y.S., Liu W.L., DuBois R.N., and Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272 (1997) 601-608
17. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., Clark A.R., et al. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20 (2000) 4265-4274
18. Delhase M., Hayakawa M., Chen Y., and Karin M. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 284 (1999) 309-313
19. Akira S. Toll-like receptor signaling. J Biol Chem 278 (2003) 38105-38108
20. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
21. Kabe Y., Ando K., Hirao S., Yoshida M., and Handa H. Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7 (2005) 395-403
22. Turini M.E., and DuBois R.N. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53 (2002) 35-57
23. Monick M.M., Robeff P.K., Butler N.S., Flaherty D.M., Carter A.B., Peterson M.W., et al. Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA. J Biol Chem 277 (2002) 32992-33000